GB201005262D0 - Granulysin and derived peptides: use as novel anthelmintic molecules - Google Patents
Granulysin and derived peptides: use as novel anthelmintic moleculesInfo
- Publication number
- GB201005262D0 GB201005262D0 GBGB1005262.9A GB201005262A GB201005262D0 GB 201005262 D0 GB201005262 D0 GB 201005262D0 GB 201005262 A GB201005262 A GB 201005262A GB 201005262 D0 GB201005262 D0 GB 201005262D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- granulysin
- molecules
- derived peptides
- novel anthelmintic
- anthelmintic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 102100021186 Granulysin Human genes 0.000 title abstract 3
- 101710168479 Granulysin Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000000507 anthelmentic effect Effects 0.000 title 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 2
- 108010029485 Protein Isoforms Proteins 0.000 abstract 2
- 208000006968 Helminthiasis Diseases 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 208000014837 parasitic helminthiasis infectious disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
- G01N2333/43526—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
- G01N2333/4353—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Disclosed are uses of granulysin, its variants, isoforms and homologues, or peptides derived by alteration of granulysin, its variants, isoforms or its homologues, in methods of diagnosing, preventing or treating helminth infections.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1005262.9A GB201005262D0 (en) | 2010-03-29 | 2010-03-29 | Granulysin and derived peptides: use as novel anthelmintic molecules |
GB1006938A GB2479212A (en) | 2010-03-29 | 2010-04-26 | Granulysin for the treatment of helminth infections |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1005262.9A GB201005262D0 (en) | 2010-03-29 | 2010-03-29 | Granulysin and derived peptides: use as novel anthelmintic molecules |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201005262D0 true GB201005262D0 (en) | 2010-05-12 |
Family
ID=42228530
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1005262.9A Ceased GB201005262D0 (en) | 2010-03-29 | 2010-03-29 | Granulysin and derived peptides: use as novel anthelmintic molecules |
GB1006938A Withdrawn GB2479212A (en) | 2010-03-29 | 2010-04-26 | Granulysin for the treatment of helminth infections |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1006938A Withdrawn GB2479212A (en) | 2010-03-29 | 2010-04-26 | Granulysin for the treatment of helminth infections |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB201005262D0 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8288509B2 (en) * | 2002-02-22 | 2012-10-16 | National Hospital Organization Kinki-chuo Chest Medical center | Therapeutic agent for infections, and treatment method using the same |
US8357365B2 (en) * | 2005-02-14 | 2013-01-22 | The Regents Of The University Of California | Granulysin peptides and methods of use thereof |
US7745390B2 (en) * | 2005-05-23 | 2010-06-29 | The Board Of Trustees Of The Leland Stanford Junior University | Antimicrobial peptides |
-
2010
- 2010-03-29 GB GBGB1005262.9A patent/GB201005262D0/en not_active Ceased
- 2010-04-26 GB GB1006938A patent/GB2479212A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2479212A (en) | 2011-10-05 |
GB201006938D0 (en) | 2010-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201291031A1 (en) | METHOD OF TREATING OBESITY WITH THE USE OF ANTIOXIDANT INFLAMMATION MODULATORS | |
MX2016002571A (en) | Transduction buffer. | |
EA201270722A1 (en) | RIFAXIMINE FORMS AND THEIR APPLICATION | |
EA201101521A1 (en) | METHODS OF TREATMENT OF ONCOLOGICAL DISEASES, USING EPIMETABOLIC SWITCHES, MULTIPLE-DIFFERENT INTRACELLULAR MOLECULES OR IMPACT FACTORS | |
TN2012000366A1 (en) | Anticoagulant antidotes | |
MX345762B (en) | Anti-infective compounds. | |
MA32161B1 (en) | Rifaximin forms and uses thereof | |
EA201791850A1 (en) | Boron-containing small molecules | |
MY169328A (en) | Compositions for the treatment of dry eye | |
MX359854B (en) | Anti-cxcr3 antibodies. | |
MX349886B (en) | Anti-pseudomonas psl binding molecules and uses thereof. | |
TW201611843A (en) | Methods of treatment with arginine deiminase | |
WO2014076321A8 (en) | Novel specific-binding polypeptides and uses thereof | |
EA201201623A1 (en) | TREATMENT OF DIABETES TYPE 2 | |
PH12014502680A1 (en) | Polysaccharide compositions and methods of use | |
EA201590503A1 (en) | ALPHA-1-Microglobulin for use in the treatment of diseases associated with mitochondria | |
MX359181B (en) | Collagen hydrolysate and use thereof. | |
TN2013000388A1 (en) | Anticoagulant antidotes | |
MX367393B (en) | ANTIFUNGAL COMPOSITIONS FOR THE TREATMENT OF SKIN and NAILS. | |
IN2014DN08385A (en) | ||
IN2014KN02914A (en) | ||
ATE532814T1 (en) | NEW AMMONIUM-POLYURETHANE AND/OR POLYCARBONATE COMPOUNDS | |
MX358132B (en) | Thrombin solution and methods of use thereof. | |
EP2597949A4 (en) | Sub-micron compositions | |
EA201590782A1 (en) | ОКСИРАНОВЫЕ АМИНЫ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |